☕ XOXO, VC Tea 👑
October 19, 2026 | Sand Hill Road's Daily Digest
|
|
Hey Upper East Siders. The venture set is playing both sides of the velvet rope: capital is flowing into care delivery and cancer interception, while Anthropic tries to earmark equity for the public good. And just as everyone asks whether AI can do the work, one old-school VC reminder is making the rounds: it still can’t shoulder the stress. Spotted, and cited.
|
💰 The Freshest Deals on the Block
Even Healthcare’s $50M round comes with a hospital-sized bet
Khosla Ventures led the all-equity Series B, with Alpha Wave also participating, at a reported $300M valuation—triple the figure 18 months earlier. Even says its two Bengaluru hospitals reached operational profitability within a year of opening, excluding depreciation; FY2025 filings still showed a ₹902M net loss on ₹272M revenue. The new capital is for five more hospitals over six months. A lovely growth story, and a very real operating bill. [TechCrunch | Even Healthcare]
Nouscom brings €120M to the cancer-interception clinic
The Swiss biotech announced an oversubscribed €120M ($135M) Series D co-led by M Ventures and Revelation Partners, with new backing from Angelini Industries, the European Investment Bank via Aurea, and Neva SGR. Proceeds will advance NOUS-209 through a global registration-enabling trial focused on cancer interception in Lynch syndrome carriers. [BioSpace | Nouscom financing]
|
🎭 The Drama Everyone’s Whispering About
Anthropic’s 5% pledge comes with footnotes
Subject to stockholder approval, Anthropic says 5% of its shares will go to a wholly owned Public Benefit Fund LLC—not a 501(c)(3). An additional 2% may be added at the board’s discretion for each 50% increase in company value; the company says it will publish more on governance and valuation milestones in the coming months. The percentage is splashy; who controls the purse is still the plot. [Anthropic | Public Benefit Fund] [TechCrunch | Anthropic fund]
Character.AI’s bankruptcy gets a Disney-sized soft landing
A court filing disclosed that Disney offered jobs to at least 60 Character.AI employees—the majority of its workforce—with estimated annual compensation of $60M; most accepted. The asset sale remains a stalking-horse bid, so another buyer could still top it. Not a whole-company rescue: jobs plus an asset bid, in court. [TechCrunch | Character.AI hiring]
|
🪑 The Partner Shuffle & New Machines
CIV gives two investors partner titles
Axios Pro reports that energy-and-advanced-manufacturing investor CIV promoted Josh Zoffer and Mitchell Brady to partner. Specialist funds are still building senior benches—even as the broader VC conversation keeps circling concentration. [Axios Pro | Climate deals]
Bucky Moore leaves Lightspeed to start his own firm
Moore is stepping down as a Lightspeed partner after joining from Kleiner Perkins early last year, Axios Pro reports, to launch a smaller-scale VC firm. No fund size was disclosed; for now, this is an announced departure and plan, not a fund close. [Axios Pro | Climate deals]
Bill Gross turns idea generation into a platform
Idealab.ai launched as a free public platform with more than 1.2 million generated business ideas, built from a system that analyzed 17 million sources. Gross wants to help people test and build companies; Cloudflare’s Matthew Prince has committed $100,000 in credits for each startup using the platform. The incubator founder is making idea sourcing a product. [Fortune | Idealab.ai]
|
🗣️ What the VCs Are Saying
Brad Gerstner: a gift, with a concentration caveat
Altimeter’s Gerstner called Anthropic’s pledge “an extraordinary gift,” while acknowledging concerns about wealth concentrated in a foundation and hoping some AI wealth reaches people directly. Applause, with a governance clause. [X | Brad Gerstner]
Mark Suster: the full text changed his mind
Upfront Ventures’ Suster said he was skeptical until reading the full text, then called the move “pretty darn innovative” and applauded it. Same pledge, warmer read. [X | Mark Suster]
Harry Stebbings: spare pre-seed founders the five-year spreadsheet
20VC’s Stebbings argues that five-year financial plans are false precision at pre-seed; he says investors should be betting on the founders’ ability to adapt. At that stage, the people are the plan. [X | Harry Stebbings]
|
🔍 The Bottom Line
Today’s money is buying operating complexity
Even has to make hospital economics work; Nouscom has to turn clinical promise into regulatory proof. Watch whether the capital buys durable outcomes—not simply a longer runway. [TechCrunch | Even Healthcare] [BioSpace | Nouscom financing]
Anthropic’s headline percentage is only the opening bid
The initial 5% is subject to shareholder approval, future increases sit with the board, and governance details are still pending. The rules—not the round number—will decide what the promise means. [Anthropic | Public Benefit Fund]
|
|
Today’s lesson? The prettiest term sheet is the one backed by measurable outcomes—and the most generous pledge still needs independent rules.
💌 Got gossip? Just hit reply and spill it—links, hot takes, or that article everyone should read. Your secret’s safe with me.
You know you love me,
XOXO
Your VC Gossip Girl 💋
|
|
Sources:
TechCrunch | Even Healthcare
BioSpace | Nouscom financing
Anthropic | Public Benefit Fund
TechCrunch | Anthropic fund
TechCrunch | Character.AI hiring
Axios Pro | Climate deals
Fortune | Idealab.ai
X | Brad Gerstner
X | Mark Suster
X | Harry Stebbings
|
